Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway
Objectives: Coronary microembolization (CME) represents a serious periprocedural complication after percutaneous coronary intervention. Ferroptosis has been identified in multiple cardiovascular diseases. In this study, we aimed to investigate the effects of atorvastatin (ATV) on ferroptosis and inf...
Main Authors: | Tao Liu, Jin Shu, Yangchun Liu, Jian Xie, Tao Li, Haoliang Li, Lang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1057583/full |
Similar Items
-
Atorvastatin Inhibits Myocardial Apoptosis in a Swine Model of Coronary Microembolization by Regulating PTEN/PI3K/Akt Signaling Pathway
by: Jiangyou Wang, et al.
Published: (2016-01-01) -
MiRNA Expression Profile of the Myocardial Tissue of Pigs with Coronary Microembolization
by: Qiang Su, et al.
Published: (2017-10-01) -
The Involvement of Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) in the Regulation of Inflammation Following Coronary Microembolization
by: Jiangyou Wang, et al.
Published: (2014-06-01) -
Levosimendan attenuates myocardial injury induced by coronary microembolization in swine by inhibiting myocardial inflammation and apoptosis
by: Han Chen, et al.
Published: (2019-01-01) -
Levosimendan Pretreatment Inhibits Myocardial Apoptosis in Swine after Coronary Microembolization
by: Lang Li, et al.
Published: (2017-01-01)